Join to View Full Profile
1365 Clifton Road NEBuilding B, 4th Floor, Suite 4000Atlanta, GA 30322
Phone+1 404-778-8057
Dr. Ozer is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Byram Ozer, MD, is a neurologist based in Atlanta, GA, with a subspecialty in neurooncology. He completed his residency in neurology and fellowship in neuro-oncology at UCLA David Geffen School of Medicine/UCLA Medical Center from 2012 to 2018. His education also includes an internship in internal medicine at TriHealth Good Samaritan Hospital in Cincinnati, OH and a medical degree from the University of Wisconsin School of Medicine & Public Health. Dr. Ozer has experience in neuro-oncology and has published several research articles in esteemed journals, focusing on topics such as characterizing rare primary CNS tumors and clinical trials and his work has been cited in other academic publications.
Education & Training
UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Neuro-Oncology, 2015 - 2018- UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Neurology, 2012 - 2015
TriHealth (Good Samaritan Hospital)Internship, Internal Medicine, 2011 - 2012
University of Wisconsin School of Medicine & Public HealthClass of 2011
Certifications & Licensure
MD State Medical License 2018 - 2027
DC State Medical License 2018 - 2026
GA State Medical License 2025 - 2026
American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2016
Publications & Presentations
PubMed
- CERN 09-02: A phase 2 trial of carboplatin and bevacizumab for recurrent adult ependymomas.Shuodan Zhang, Byram H Ozer, Antonio Omuro, Ying Yuan, Tito Mendoza
Neuro-Oncology Advances. 2026-03-09 - 1 citationsPhase I/II and window-of-opportunity study of pamiparib and metronomic temozolomide for recurrent isocitrate dehydrogenase mutant gliomas.David Schiff, Xiaobu Ye, Jing Li, Benjamin M Ellingson, Patrick Y Wen
Neuro-Oncology. 2026-02-01 - Combination of metronomic oral pazopanib and topotecan for recurrent glioblastoma with and without previous bevacizumab: Results from a phase 2 clinical trial.Byram H Ozer, Adam L Cohen, Howard Colman, Marta Penas-Prado, John de Groot
Neuro-Oncology Advances. 2026-01-23
Press Mentions
Study Identifies Link Between Glioma & Common Foodborne PathogenFebruary 28th, 2021
Grant Support
- Brain Tumor Clinical and Clinical Research ProgramDIVISION OF BASIC SCIENCES - NCIPresent
Professional Memberships
- Member
- Society for Neuro-Oncology - SNOMember
Other Languages
- German
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
